Journal profile · Pathology
Ultrastructural Pathology
ISSN 0191-3123 · eISSN 1521-0758 · Informa Healthcare · UNITED STATES · Bimonthly · Founded 1980
Ultrastructural Pathology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.17; subscription journal; median 60 days to acceptance (84 articles, last 24 months); community-reported acceptance: easy; 42 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Ultrastructural Pathology is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Renal Diseases and Glomerulopathies and Medical Imaging and Pathology Studies, together about 26.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Aims and scopeJournal metrics Editorial board Ultrastructural Pathology is the official journal of the Society for Ultrastructural Pathology . Published bimonthly, we are the only journal to be devoted entirely to diagnostic ultrastructural pathology. Ultrastructural Pathology is the ideal journal to publish high-quality research on the following topics: Advances in the uses of electron microscopic and immunohistochemical techniques Correlations of ultrastructural data with light microscopy, histochemistry, immunohistochemistry, biochemistry, cell and tissue culturing, and electron probe analysis Important new, investigative, clinical, and diagnostic EM methods We welcome you to contribute to the journal to uphold our efforts to ensure Ultrastructural Pathology is the real voice of those actively engaged in providing ultrastructural support in diagnostic and experimental fields.Editor-in-Chief, Dr Guillermo Herrera, leads an expert editorial board who are very sensitive to the need to provide proper, comprehensive, and timely feedback to all authors. Read full aims and scope
From the journal's Aims & Scope
Research area (LetPub): Pathology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine13.5%
- Renal Diseases and GlomerulopathiesMedicine6.6%
- Medical Imaging and Pathology StudiesMedicine6.5%
- Soft tissue tumor case studiesMedicine6.1%
- Neuroendocrine Tumor Research AdvancesMedicine4.5%
- Neuroblastoma Research and TreatmentsMedicine4.5%
- Tumors and Oncological CasesMedicine4.2%
- Oral and Maxillofacial PathologyDentistry4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Microscopy | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Microscopy | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Microscopy | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.17LetPub ·
- CiteScore 2026-06
- 2.3LetPub ·
- SJR 2026-06
- 0.36LetPub ·
- SNIP 2026-06
- 0.4LetPub ·
- h-index
- 39LetPub ·
- h-index
- 70OpenAlex ·
- i10-index
- 1,279OpenAlex ·
- 2-year mean citedness
- 1.09OpenAlex ·
- Self-citation rate
- 16.7%LetPub ·
- Share of gold OA articles
- 1.55%LetPub ·
Volume
- Articles per year
- 43LetPub ·
Articles by year OpenAlex count · 2,878 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 32 | 4 | 0 |
| 2025 | 42 | 7 | 37 |
| 2024 | 38 | 6 | 85 |
| 2023 | 54 | 10 | 200 |
| 2022 | 41 | 5 | 267 |
| 2021 | 32 | 5 | 252 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
60 daysMedian, submission to acceptance · P25–P75 36 days – 83 days
- Acceptance to online
- median 9 days (84 articles)
- Submission to online
- median 70 days
- Sample
- 84 articles with submission and acceptance dates (85 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Overview Open journals Open Select Dove Medical Press F1000Research
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1980
- ISSN
- 0191-3123
- Electronic ISSN
- 1521-0758
- Society / sponsor
- Society for Ultrastructural Pathology
- Latest issue on the website
- Volume 50, Issue 4 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Ultrastructural Pathology
What CAS zone is Ultrastructural Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Ultrastructural Pathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Microscopy / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Ultrastructural Pathology?
The latest impact factor listed by LetPub is 1.17; CiteScore 2.3, h-index 70.
How long does peer review take at Ultrastructural Pathology?
Based on the dates recorded on 84 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 60 days (interquartile range 36–83 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Ultrastructural Pathology?
According to LetPub and DOAJ records, Ultrastructural Pathology is indexed in SCIE and Scopus.
Is Ultrastructural Pathology open access, and what is the APC?
Ultrastructural Pathology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .